45 related articles for article (PubMed ID: 20392237)
1. Purification and identification of estrogen receptor alpha co-regulators in osteoclasts.
Takada I; Tsuji N; Youn MY; Fujiyama S; Okada M; Imai Y; Kondo S; Kitakawa H; Yasuda H; Kato S
Ann N Y Acad Sci; 2010 Mar; 1192():201-7. PubMed ID: 20392237
[TBL] [Abstract][Full Text] [Related]
2. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts.
Nakamura T; Imai Y; Matsumoto T; Sato S; Takeuchi K; Igarashi K; Harada Y; Azuma Y; Krust A; Yamamoto Y; Nishina H; Takeda S; Takayanagi H; Metzger D; Kanno J; Takaoka K; Martin TJ; Chambon P; Kato S
Cell; 2007 Sep; 130(5):811-23. PubMed ID: 17803905
[TBL] [Abstract][Full Text] [Related]
3. Estrogens maintain bone mass by regulating expression of genes controlling function and life span in mature osteoclasts.
Imai Y; Youn MY; Kondoh S; Nakamura T; Kouzmenko A; Matsumoto T; Takada I; Takaoka K; Kato S
Ann N Y Acad Sci; 2009 Sep; 1173 Suppl 1():E31-9. PubMed ID: 19751412
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts.
Takeshita S; Kaji K; Kudo A
J Bone Miner Res; 2000 Aug; 15(8):1477-88. PubMed ID: 10934646
[TBL] [Abstract][Full Text] [Related]
5. RANKL regulates Fas expression and Fas-mediated apoptosis in osteoclasts.
Wu X; Pan G; McKenna MA; Zayzafoon M; Xiong WC; McDonald JM
J Bone Miner Res; 2005 Jan; 20(1):107-16. PubMed ID: 15619676
[TBL] [Abstract][Full Text] [Related]
6. The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors.
Kwon OH; Lee CK; Lee YI; Paik SG; Lee HJ
Biochem Biophys Res Commun; 2005 Sep; 335(2):437-46. PubMed ID: 16083856
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor-beta modulates synthesis of bone matrix proteins in human osteoblast-like MG63 cells.
Cao L; Bu R; Oakley JI; Kalla SE; Blair HC
J Cell Biochem; 2003 May; 89(1):152-64. PubMed ID: 12682916
[TBL] [Abstract][Full Text] [Related]
8. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M
APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
[TBL] [Abstract][Full Text] [Related]
9. Commitment and differentiation of stem cells to the osteoclast lineage.
Hayashi S; Yamane T; Miyamoto A; Hemmi H; Tagaya H; Tanio Y; Kanda H; Yamazaki H; Kunisada T
Biochem Cell Biol; 1998; 76(6):911-22. PubMed ID: 10392705
[TBL] [Abstract][Full Text] [Related]
10. Estrogen-triggered delays in mammary gland gene expression during the estrous cycle: evidence for a novel timing system.
Silberstein GB; Van Horn K; Hrabeta-Robinson E; Compton J
J Endocrinol; 2006 Aug; 190(2):225-39. PubMed ID: 16899557
[TBL] [Abstract][Full Text] [Related]
11. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
[TBL] [Abstract][Full Text] [Related]
12. Expression profile of RhoGTPases and RhoGEFs during RANKL-stimulated osteoclastogenesis: identification of essential genes in osteoclasts.
Brazier H; Stephens S; Ory S; Fort P; Morrison N; Blangy A
J Bone Miner Res; 2006 Sep; 21(9):1387-98. PubMed ID: 16939397
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency.
Kanematsu M; Sato T; Takai H; Watanabe K; Ikeda K; Yamada Y
J Bone Miner Res; 2000 Jul; 15(7):1321-9. PubMed ID: 10893680
[TBL] [Abstract][Full Text] [Related]
14. Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancer.
Lin Z; Reierstad S; Huang CC; Bulun SE
Cancer Res; 2007 May; 67(10):5017-24. PubMed ID: 17510434
[TBL] [Abstract][Full Text] [Related]
15. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
Kanazawa K; Kudo A
J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857
[TBL] [Abstract][Full Text] [Related]
16. Expression of estrogen receptor-alpha in cells of the osteoclastic lineage.
Oreffo RO; Kusec V; Virdi AS; Flanagan AM; Grano M; Zambonin-Zallone A; Triffitt JT
Histochem Cell Biol; 1999 Feb; 111(2):125-33. PubMed ID: 10090573
[TBL] [Abstract][Full Text] [Related]
17. Unraveling estrogen action in osteoporosis.
Krum SA; Brown M
Cell Cycle; 2008 May; 7(10):1348-52. PubMed ID: 18418063
[TBL] [Abstract][Full Text] [Related]
18. Modest Effects of Osteoclast-Specific ERĪ± Deletion after Skeletal Maturity.
Doolittle ML; Eckhardt BA; Vos SJ; Grain S; Rowsey JL; Ruan M; Saul D; Farr JN; Weivoda MM; Khosla S; Monroe DG
JBMR Plus; 2023 Oct; 7(10):e10797. PubMed ID: 37808391
[TBL] [Abstract][Full Text] [Related]
19. GST-tagged mouse estrogen receptor alpha-transactivation domain fusion protein is specifically degraded during its over-expression in E. coli and purification.
Thakur MK; Ghosh S
Mol Biol Rep; 2010 Mar; 37(3):1335-40. PubMed ID: 19319663
[TBL] [Abstract][Full Text] [Related]
20. Estrogen regulation of myokines that enhance osteoclast differentiation and activity.
Norton A; Thieu K; Baumann CW; Lowe DA; Mansky KC
Sci Rep; 2022 Sep; 12(1):15900. PubMed ID: 36151243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
